Neurogenic pulmonary oedema in a patient with leptomeningeal carcinomatosis

Por Dammers, R, van den Bent, M J, Dammers, R
Publicado em 2006

Hemangioblastomatosis in a patient with von Hippel-Lindau disease

Por Hanse, M. C. J., Vincent, A., van den Bent, M. J.
Publicado em 2007

Increased rCBV in status epilepticus

Por Rath, J. J. G., Smits, M., Ducray, F., van den Bent, M. J.
Publicado em 2012

Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors

Por de Brabander, C, Cornelissen, J, Smitt, P, Vecht, C., van den Bent, M J
Publicado em 2000

EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab

Por van de Langerijt, B., Doorduijn, J. K., Lam, K. H., van den Bent, M. J.
Publicado em 2010

Leptomeningeal metastasis after surgical resection of brain metastases

Por van der Ree, T. C, Dippel, D., Avezaat, C, Smitt, P, Vecht, C., van den Bent, M. J
Publicado em 1999

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.

Por Hilkens, P. H., Pronk, L. C., Verweij, J., Vecht, C. J., van Putten, W. L., van den Bent, M. J.
Publicado em 1997

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.

Por Planting, A. S., van der Burg, M. E., van den Bent, M. J., de Boer-Dennert, M., Stoter, G., Verweij, J.
Publicado em 1996

P07.03 RECURRENT MEDULLOBLASTOMA AND CNS PNET IN ADULTS - RESULTS OF VIP CHEMOTHERAPY

Por Gravendeel, L.A., van den Bent, M.J., Taal, W., van der Rijt, C.C.D., Bromberg, J.E.C.
Publicado em 2014

Acute painful lumbosacral paresthesia after intrathecal rituximab

Por Bromberg, J. E. C., Doorduijn, J. K., Baars, J. W., van Imhoff, G. W., Enting, R., van den Bent, M. J.
Publicado em 2011

P10.03 Management of low-grade glioma: a systematic review and meta-analysis

Por Brown, T. J., Bota, D., Maher, E., Aregawi, D., Liau, L. M., Buckner, J., Weller, M., van den Bent, M. J., Berger, M. S., Glantz, M.
Publicado no Neuro Oncol (2017)

EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int...

Por van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.
Publicado no Neuro Oncol (2016)

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material

Por Gravendeel, L A M, de Rooi, J J, Eilers, P H C, van den Bent, M J, Sillevis Smitt, P A E, French, P J
Publicado em 2012

OS5.2 Health-Related Quality of Life (HRQoL) in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only (randomized phase III E...

Por Taphoorn, M. J. B., Bottomley, A., Coens, C., Reijneveld, J. C., Gorlia, T., Brandes, A. A., Domont, J., Idbaih, A., van den Bent, M. J., Wick, W.
Publicado no Neuro Oncol (2016)

OS5.7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma

Por Idbaih, A., Clement, P. M., Vos, F. Y. F., Platten, M., Mulholland, P., Taphoorn, M. J. B., Lewis, L., Golfinopoulos, V., Gorlia, T., van den Bent, M. J.
Publicado no Neuro Oncol (2016)

Involvement of the peripheral nervous system in primary Sjögren's syndrome

Por Barendregt, P, van den Bent, M J, van Raaij-van, den... V J M, van den Meiracker, A H, Vecht, C., van der Heijde, G L, Markusse, H
Publicado em 2001

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

Por de Jongh, F E, van Veen, R N, Veltman, S J, de Wit, R, van der Burg, M E L, van den Bent, M J, Planting, ASTh, Graveland, W J, Stoter, G, Verweij, J
Publicado em 2003

OS5.6 Initial treatment strategy for presumed low-grade glioma: a preoperative perspective

Por Wijnenga, M. M. J., Mattni, T., French, P. J., Rutten, G. J., Leenstra, S., Kloet, F., Taphoorn, M. J. B., van den Bent, M. J., van Veelen, M. L. C., Vincent, A. J. P. E.
Publicado no Neuro Oncol (2016)

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer

Por Schellens, J H M, Planting, ASTh, van Zandwijk, N, Ma, J, Maliepaard, M, van der Burg, M E L, de Boer-Dennert, M, Brouwer, E, van der Gaast, A, van den Bent, M J, Verweij, J
Publicado em 2003

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain T...

Por Mauer, M, Stupp, R, Taphoorn, M J B, Coens, C, Osoba, D, Marosi, C, Wong, R, de Witte, O, Cairncross, J G, Efficace, F, Mirimanoff, R O, Forsyth, P, van den Bent, M J, Weller, M, Bottomley, A
Publicado em 2007